Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.42 USD | +1.74% | -0.93% | +3.55% |
Apr. 17 | Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating | MT |
Apr. 05 | Leerink Partners Initiates Coverage on Ardelyx With Outperform Rating, $14 Price Target | MT |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 52 | 100.0 % | 124 | 100.0 % | +138.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
66.9
%
| 16 | 29.9 % | 83 | 66.9 % | +433.82% |
Asia Pacific
33.0
%
| 37 | 70.0 % | 41 | 33.0 % | +12.58% |
North America
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | +90.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mike Raab Raab
CEO | Chief Executive Officer | 59 | 09-02-28 |
Justin Renz
DFI | Director of Finance/CFO | 52 | 20-06-08 |
Laura Williams
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-10-31 |
Chief Administrative Officer | 60 | 12-11-30 | |
Caitlin Lowie
IRC | Investor Relations Contact | - | 22-10-31 |
Charon Spencer
HRO | Human Resources Officer | - | 22-12-31 |
Robert Felsch
AUD | Comptroller/Controller/Auditor | - | 22-01-31 |
David Rosenbaum
PRN | Corporate Officer/Principal | 63 | 09-12-31 |
Susan Rodriguez
PRN | Corporate Officer/Principal | 60 | 20-05-17 |
Robert Blanks
LAW | General Counsel | 64 | 13-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Bertrand
BRD | Director/Board Member | 59 | 15-10-25 |
Richard Rodgers
BRD | Director/Board Member | 57 | 14-02-28 |
David Mott
CHM | Chairman | 58 | 09-02-28 |
Jan Lundberg
BRD | Director/Board Member | 70 | 18-03-22 |
Mike Raab Raab
CEO | Chief Executive Officer | 59 | 09-02-28 |
Director/Board Member | 60 | 20-03-11 | |
Director/Board Member | 56 | 16-06-01 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 21-03-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 232,686,008 | 228,165,062 ( 98.06 %) | 0 | 98.06 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.55% | 1.49B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARDX Stock
- Company Ardelyx, Inc.